HUP9903711A2 - Chemokine beta-15 - Google Patents

Chemokine beta-15

Info

Publication number
HUP9903711A2
HUP9903711A2 HU9903711A HUP9903711A HUP9903711A2 HU P9903711 A2 HUP9903711 A2 HU P9903711A2 HU 9903711 A HU9903711 A HU 9903711A HU P9903711 A HUP9903711 A HU P9903711A HU P9903711 A2 HUP9903711 A2 HU P9903711A2
Authority
HU
Hungary
Prior art keywords
amino acid
acid sequence
polypeptide
encoding
atcc
Prior art date
Application number
HU9903711A
Other languages
Hungarian (hu)
Inventor
Brent L. Kreider
Craig A. Rosen
Ying-Fei Wei
Original Assignee
Human Genome Sciences, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences, Inc. filed Critical Human Genome Sciences, Inc.
Publication of HUP9903711A2 publication Critical patent/HUP9903711A2/en
Publication of HUP9903711A3 publication Critical patent/HUP9903711A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

An isolated nucleic acid molecule comprises a polynucleotide (PN) having a nucleotide sequence (NS) at least 95% identical to a sequence selected from:(a) a NS encoding the chemokine ~b-15 (CB15) polypeptide having the 149 amino acid sequence given in the specification; (b) a NS encoding the mature CB15 polypeptide having an amino acid sequence from positions 1-129 of the 149 amino acid sequence; (c) a NS encoding the CB15 polypeptide having the complete amino acid sequence encoded by the cDNA clone contained in ATCC No. 97519; (d) a NS encoding the mature CB15 polypeptide having the amino acid sequence encoded by the cDNA clone contained in ATCC No: 97519; and (e) a NS complementary to a NS as in (a)-(d).
HU9903711A 1996-06-17 1996-06-17 Chemokine beta-15 HUP9903711A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1996/010561 WO1997048807A1 (en) 1996-06-17 1996-06-17 CHEMOKINE β-15
CA002258507A CA2258507A1 (en) 1996-06-17 1996-06-17 Chemokine beta-15

Publications (2)

Publication Number Publication Date
HUP9903711A2 true HUP9903711A2 (en) 2000-03-28
HUP9903711A3 HUP9903711A3 (en) 2001-12-28

Family

ID=25680722

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9903711A HUP9903711A3 (en) 1996-06-17 1996-06-17 Chemokine beta-15

Country Status (7)

Country Link
EP (1) EP0909320A4 (en)
JP (1) JP2000515733A (en)
AU (1) AU738116B2 (en)
CA (1) CA2258507A1 (en)
HU (1) HUP9903711A3 (en)
IL (1) IL127551A0 (en)
WO (1) WO1997048807A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329159B1 (en) 1999-03-11 2001-12-11 Millennium Pharmaceuticals, Inc. Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function

Also Published As

Publication number Publication date
HUP9903711A3 (en) 2001-12-28
WO1997048807A1 (en) 1997-12-24
CA2258507A1 (en) 1997-12-24
IL127551A0 (en) 1999-10-28
EP0909320A4 (en) 2004-12-01
AU6335896A (en) 1998-01-07
JP2000515733A (en) 2000-11-28
AU738116B2 (en) 2001-09-06
EP0909320A1 (en) 1999-04-21

Similar Documents

Publication Publication Date Title
TW327194B (en) Novel amyloid precursor proteins and methods of using same
PL332851A1 (en) Novel homoloques of fibroblast growth factor
WO1999019492A3 (en) Methods for obtaining plant varieties
IL193886A (en) Antibodies that bind to ldcam sequences
EP2455468A3 (en) Amylase variants
WO1998021328A3 (en) Human proteins having transmembrane domains and dnas encoding these proteins
CA2266319A1 (en) Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
CA2200563A1 (en) Calcium free subtilisin mutants
CA2249233A1 (en) Mch4 and mch5, apoptotic protease, nucleic acids encoding and methods of use
EP1681350A3 (en) Porphorymonas gingivalis polypeptides and polynucleotides
CA2262465A1 (en) Neuritin, a neurogene
WO1997027276A3 (en) Nucleic acids encoding polypeptides having absidia lipase activity
WO1998042827A3 (en) Gene encoding oxalate decarboxylase from aspergillus phoenicis
AU6724794A (en) GRB3-3 gene, its variants and their uses
EP0785716A4 (en) Cytokine designated lerk-6
HUP9903711A2 (en) Chemokine beta-15
AU3711597A (en) A novel galanin receptor
AU1981295A (en) Novel protein-kinase, nucleic acid sequences encoding the same and methods related thereto
CA2197651A1 (en) Or-1 on orphan receptor belonging to the nuclear receptor family
EP0919621A4 (en) Human taki dna encoding the same
EP1013665A4 (en) Novel polypeptide having water channel activity and dna sequence
WO2001092468A3 (en) Novel compositions for the expression of the human peptide histidine transporter 1 and methods of use thereof
EP0945512A3 (en) Novel serine proteases
CA2260366A1 (en) Recombinant n-proteinase, and the production, methods and uses thereof
EP1632573A3 (en) Modulation of sodium channels in dorsal root ganglia